4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0000899243-16-034052
Director sold 45,324 shares at an average $11.61 ($526,088)
From the SEC's structured data for this filing
Trades in this filing
Canaan IX L.P. · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-11-17 | Sale : show line 1 in the form | −18,971 | $11.50 | $218,218 | 3,773,829 | I |
| 2016-11-18 | Sale : show line 2 in the form | −12,805 | $11.64 | $149,085 | 3,761,024 | I |
| 2016-11-21 | Sale : show line 3 in the form | −13,548 | $11.72 | $158,785 | 3,747,476 | I |
| Open-market sales · 45,324 sh · avg $11.61 · $526,088 | ||||||
Loading xslF345X03/doc4.xml…